Tampa General, UT Southwestern Test GE HealthCare’s Oncology Application
GE HealthCare (Nasdaq: GEHC) says that Tampa General Hospital and UT Southwestern Medical Center are early evaluators of an oncology application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports.
The company said the CareIntellect for Oncology application, which will be available next year, also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help clinicians determine potential next steps and inform proactive interventions.
The application will initially focus on prostate and breast cancer. It organizes structured and unstructured data, summarizes complex medical histories, supports treatment response assessments, helps assess clinical trial eligibility, and tracks adherence to treatment protocols in an easy-to-navigate view.
The oncology application is the GE HealthCare’s new CareIntellect offering of clinical and operational applications designed to help healthcare providers quickly and easily install new applications without having to take a costly and time-consuming product-by-product integration approach. CareIntellect applications will use a common, cloud-first digital infrastructure, the company said, and will be compatible with providers’ existing single sign-on systems to avoid the hassle of multiple log-ins.
The company said that CareIntellect for Oncology quickly organizes multi-modal patient data from disparate systems to provide care teams with a concise view of the patient’s progressive treatment journey, while allowing clinicians to maintain full access to the source reports. The application will allow care teams to reduce or eliminate the time-consuming task of searching multiple databases—reducing a process that can take several hours, down to several minutes by eliminating the need to track down and synthesize information across multiple reports.
The application is also able to flag risk of deviation from the treatment plan, helping the clinician determine potential next steps to intervene—for example, surfacing a patient’s missed lab work that could delay the next round of treatment. Additionally, CareIntellect for Oncology helps care teams assess potentially suitable clinical trials by comparing the patient’s health record to trial criteria.
“Tampa General Hospital is looking forward to evaluating CareIntellect for Oncology to provide our care teams with information to move from analysis to action—including making use of the proactive pathways to inform care progression and clinical trial eligibility information,” said Peter Chang, M.D., senior vice president, chief transformation officer at Tampa General Hospital, in a statement. “We were impressed by how quickly GE HealthCare was able to design the application to include breast cancer in a matter of weeks. We look forward to putting this in the hands of our care teams and using the AI-enabled functionality to help clinicians spend time where it matters most—delivering outstanding patient care.”
GE HealthCare also announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company.
